Boston University is a private research university in Boston, Massachusetts. The university is nonsectarian, but has a historical affiliation with the United Methodist Church. It was founded in 1839 by Methodists with its original campus in Newbury, Vermont, before moving to Boston in 1867.

During the past decade, Boston University conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 31 clinical trials were completed, i.e. on average, 43.7% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 19 clinical trials were completed. i.e. 52.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston University" #1 sponsor was "Boston University Charles River Campus" with 36 trials, followed by "Boston University" with 11 trials sponsored, "Boston Medical Center" with 3 trials sponsored, "NICHD Global Network for Women's and Children's Health" with 3 trials sponsored and "University of Washington" with 3 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston University" #1 collaborator was "Boston University" with 10 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator, "National Institute on Aging (NIA)" with 6 trials as a collaborator and "National Institute on Deafness and Other Communication Disorders (NIDCD)" with 5 trials as a collaborator. Other collaborators include 154 different institutions and companies that were collaborators in the rest 131 trials.

According to Clinical.Site data, the most researched conditions in "Boston University" are "Parkinson Disease" (5 trials), "Stroke" (5 trials), "Depression" (4 trials), "Panic Disorder" (4 trials) and "Social Anxiety Disorder" (4 trials). Many other conditions were trialed in "Boston University" in a lesser frequency.

Most popular intervention types in "Boston University" are "Drug" (52 trials), "Behavioral" (43 trials), "Other" (15 trials), "Procedure" (7 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (4 trials), "D-cycloserine" (3 trials), "Abatacept" (2 trials) and "Ascorbic Acid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Boston University" are 107 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 30 active trials in "Boston University". 2 are not yet recruiting, 21 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 66 completed trials in Boston University, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Boston University, 6 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 46 trials that are defined as “Not Applicable".

Boston University has several departments that took part in Clinical trials: "Boston University Cancer Research Center" - 67 trials, "Center for Anxiety and Related Disorders at Boston University" - 14 trials, "Henry M. Goldman School of Dental Medicine" - 11 trials, "Boston University Psychiatry Research Center, Clinical Studies Unit" - 6 trials, "Boston University School of Medicine, Alzheimer's Disease Center" - 4 trials, "Center for Neurorehabilitation, College of Health & Rehabilitation Sciences, Sargent College, Boston University" - 3 trials, "Boston University Center for Psychiatric Rehabilitation" - 3 trials, "General Clinical Research Unit, Boston University" - 2 trials, "Boston University Department of Psychological and Brain Sciences" - 2 trials, "Boston University School of Medicine; Rheumatology/Arthritis Center" - 2 trials, "Slone Epidemiology Center at Boston University" - 2 trials